Characteristics of patients with bronchoscopic RML reduction with EBVs
Case reports | This case | Case 2 [8] | Case 3 [8] | Case 4 [8] | Case 5 [7] | Case 6 [6] |
Demographics and clinical data | ||||||
Sex | Male | Male | Female | Male | Male | Female |
Age, years | 57 | 52 | 66 | 50 | 65 | 65 |
Smoking status (pack-years) | Past (50) | Past (35) | Past (20) | Past | Past (80) | Past (20) |
mMRC class | 4 | |||||
6MWD, m | 250 | 230 | ||||
EBV target | RML emphysema | RML bulla | RML bulla | RML bulla | RML bulla 15.0×10.1 cm | RML bulla 12.7×10.1 cm |
Pulmonary function tests | ||||||
RV, L (% pred) | 8 (340) | 5.37 (215.8) | 6.43 (275) | 3.54 (182) | ||
FVC, L (% pred) | 2.3 (49) | |||||
FEV1, L (% pred) | 0.8 (23) | 1.07 (35.4) | 0.71 (38.3) | 0.74 (19.7) | 0.41 (13) | 0.74 (36) |
After EBV procedure | ||||||
Follow-up, months | 2 | 6 | 6 | 6 | 2 | 12 |
mMRC class | 2 (+2) | |||||
RV, L (gain) | 5.9 (−2.1 L) | 4.74 (−1.69 L) | 2.89 (−0.65 L) | |||
FVC, L (gain, L and %) | 3.5 (+1.2 L, +52%) | |||||
FEV1, L (gain, mL and %) | 1.2 (+400 mL, +50%) | 1.75 (+680 mL, +63%) | 1.03 (+320 mL, +45%) | 0.83 (+90 mL, +12%) | 0.58 (+170 mL, +41%) | 0.86 (+120 mL, +16%) |
6MWD, m (change m and % gain) | 360 (+110 m, 31%) | 300 (+70 m) | ||||
Outcome | Improved | Improved | Improved | No benefit | Improved | Improved |